🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0950
+0.0050 (5.56%)
Nov 20, 2026, 3:12 PM EST

Rapid Dose Therapeutics Statistics

Total Valuation

CSE:DOSE has a market cap or net worth of CAD 13.09 million. The enterprise value is 18.96 million.

Market Cap13.09M
Enterprise Value 18.96M

Important Dates

The next estimated earnings date is Friday, January 29, 2027.

Earnings Date Jan 29, 2027
Ex-Dividend Date n/a

Share Statistics

CSE:DOSE has 137.78 million shares outstanding. The number of shares has increased by 5.11% in one year.

Current Share Class 137.78M
Shares Outstanding 137.78M
Shares Change (YoY) +5.11%
Shares Change (QoQ) -0.22%
Owned by Insiders (%) 15.19%
Owned by Institutions (%) n/a
Float 116.86M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.18
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 21.24
P/OCF Ratio 21.24
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.95
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 30.76

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.02
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF 9.54
Interest Coverage -1.48

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -32.66%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 29.67%
Weighted Average Cost of Capital (WACC) 4.74%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.59
Inventory Turnover 7.13

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -47.22% in the last 52 weeks. The beta is -0.91, so CSE:DOSE's price volatility has been lower than the market average.

Beta (5Y) -0.91
52-Week Price Change -47.22%
50-Day Moving Average 0.10
200-Day Moving Average 0.11
Relative Strength Index (RSI) 47.31
Average Volume (20 Days) 26,560

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CSE:DOSE had revenue of CAD 2.12 million and -3.14 million in losses. Loss per share was -0.02.

Revenue2.12M
Gross Profit 1.04M
Operating Income -1.88M
Pretax Income -3.14M
Net Income -3.14M
EBITDA -1.73M
EBIT -1.88M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 8,625 in cash and 5.88 million in debt, with a net cash position of -5.87 million or -0.04 per share.

Cash & Cash Equivalents 8,625
Total Debt 5.88M
Net Cash -5.87M
Net Cash Per Share -0.04
Equity (Book Value) -8.20M
Book Value Per Share -0.06
Working Capital -9.00M
Full Balance Sheet

Cash Flow

Operating Cash Flow 616,342
Capital Expenditures n/a
Depreciation & Amortization 141,558
Net Borrowing -2.69M
Free Cash Flow 616,342
FCF Per Share 0.00
Full Cash Flow Statement

Margins

Gross margin is 49.12%, with operating and profit margins of -88.50% and -148.27%.

Gross Margin 49.12%
Operating Margin -88.50%
Pretax Margin -148.27%
Profit Margin -148.27%
EBITDA Margin -81.82%
EBIT Margin -88.50%
FCF Margin 29.09%

Dividends & Yields

CSE:DOSE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -5.11%
Shareholder Yield -5.11%
Earnings Yield -24.44%
FCF Yield 4.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CSE:DOSE has an Altman Z-Score of -27.71 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -27.71
Piotroski F-Score 2